Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 5

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 5
---
 approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                      | Page |
| ABOUT THIS PROSPECTUS                                |    1 |
| PRESENTATION OF FINANCIAL AND OTHER INFORMATION      |    2 |
| MARKET AND INDUSTRY DATA                             |    3 |
| PROSPECTUS SUMMARY                                   |    4 |
| RISK FACTORS                                         |   10 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS |   11 |
| THE COMMITTED EQUITY FINANCING                       |   13 |
| USE OF PROCEEDS                                      |   18 |
| DIVIDEND POLICY                                      |   19 |
| CAPITALIZATION                                       |   20 |
| DESCRIPTION OF SHARE CAPITAL                         |   21 |
| DESCRIPTION OF AMERICAN DEPOSITARY SHARES            |   49 |
| TAXATION                                             |   66 |
| SELLING SHAREHOLDER                                  |   73 |
| PLAN OF DISTRIBUTION                                 |   75 |
| EXPENSES OF THE OFFERING                             |   76 |
| LEGAL MATTERS                                        |   76 |
| EXPERTS                                              |   77 |
| ENFORCEMENT OF CIVIL LIABILITIES                     |   77 |
| WHERE YOU CAN FIND MORE INFORMATION                  |   77 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE    |   78 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This
prospectus is part of a registration statement on Form F-1 that we filed with the SEC whereby the Selling Shareholder named
herein may, from time to time, sell the securities offered by it described in this prospectus. We will not receive any proceeds from the
sale by such Selling Shareholder of the securities offered by it described in this prospectus.

Neither
we nor the Selling Shareholder has authorized anyone to provide you with any information or to make any representations other than those
contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or
to which we have referred you. Neither we nor the Selling Shareholder take responsibility for, and can provide no assurance as to the